Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Schering-Plough and Chiroscience to collaborate on asthma and inflammatory disease treatments

July 1, 1997

Ube/Tanabe evaluating orally active antiallergic/antiasthmatic agent

June 30, 1997

Arris reports positive results from phase IIa trial of tryptase inhibitor for asthma

June 30, 1997

Disappointing phase III results for Ventus

June 30, 1997

Ono describes elastase inhibitors

June 26, 1997

Pharmacokinetics of two methylprednisolone prodrugs compared in asthmatics

June 25, 1997

Pulmicort Turbuhaler approved by FDA

June 25, 1997

Antiasthmatic activity of NPC-17731 in primate model

June 24, 1997

Recombinant PAF-AH progresses to phase II for ARDS

June 24, 1997

New orally active oligopeptide antiallergic from Central Drug Res. Inst.

June 23, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...